Obermatt
See Similar Stocks →

Baxter

NYQ:BAX · US0718131099
Health Care Equipment & SuppliesX-Large

360

2
EV / EBIT81
Price / Owner Earnings87
Owner Earnings Yield1
Dividend Yield89
Price/Sales85
EV / Gross Profit58
Price/Book70
Return on Capital21
Cash Return on Capital15
Return on Equity13
EBIT Margin20
Gross Profitability11
Accruals87
Owner Earnings Margin17
Sales growth19
Profit Growth79
Long-Term EPS Growth19
Owner Earnings Growth7
Reinvestment26
Price momentum24
Debt load24
Refinancing86
Debt Payback1
Liquidity64
Analyst ratings3
Opinion Changes17
Price Target Upside14
Market mood17
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Baxter doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
TypePublic Company
ExchangeNYSE
Founded1931
Employees24,688
Websitebaxter.com
ISINUS0718131099
Last UpdateApr 2, 2026
Indices
S&P 500 (USA)D.J. US Health CareD.J. US Medical Equipment
Themes
Health DiagnosticsRespiratoryCardiovascularPain ManagementSurgeryBiotechnologyClinical TrialsMedical

Description

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anest…

Analysis

Weak and unloved

Baxter International Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is weak; the safety picture is fragile. The company scores 4/20 on our value-creation score: not creating value.

Flags to be aware of: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
49
2023202420252026

All-time high

98

Jan 2023

All-time low

21

Nov 2025

Average rank

56

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
85
57
74
48
Price/Earnings
57
55
64
50
Price/Book
70
52
41
44
Dividend Yield
89
82
98
96
Value (overall)
100
100
100
98

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Baxter with its peers
Apyx Medical
NSQ:APYX
34
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
GE Healthcare
NSQ:GEHC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Teleflex
NYQ:TFX
5
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Masimo
NSQ:MASI
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
IRadimed
NMQ:IRMD
64
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Omnicell
NSQ:OMCL
80
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →